Chronic Insomnia: In an open-label study involving patients with severe chronic insomnia, a treatment regimen of 10 intravenous injections of DSIP (25 nmol/kg) resulted in a normalization of sleep patterns that persisted for follow-up periods of 3 to 7 months.Crucially, the patients reported not just improved sleep duration, but improved daytime mood and performance, distinguishing DSIP from benzodiazepines which often cause daytime drowsiness and cognitive impairment
Subsequently, we examined molecules of the GLP-1/GLP-1R/PKA signaling pathway in pancreatic and intestinal tissues and found that their expression was increased
This focused approach may enhance therapeutic outcomes, as glutathione reaches affected areas more efficiently
Sale restricted to registered research entities and laboratories
It is a prescription medicine and the examination before prescribing is a full medical safety assessment, not a formality
Smith PD, Ochsenbauer-Jambor C, Smythies LE (2005) Intestinal macrophages: unique effector cells of the innate immune system
